(3R,4R)-3-amino-1-(2-aminopropylsulfamoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid
C11H25BN4O6S — CID 155627365
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R,4R)-3-amino-1-(2-aminopropylsulfamoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid
(3R,4R)-3-amino-1-(2-aminopropylsulfamoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid (PubChem CID 155627365) has the molecular formula C11H25BN4O6S and a molecular weight of 352.22 g/mol. Its IUPAC name is (3R,4R)-3-amino-1-(2-aminopropylsulfamoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid.
Molecular Properties
| Compound Name | (3R,4R)-3-amino-1-(2-aminopropylsulfamoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid |
|---|---|
| PubChem CID | 155627365 |
| Molecular Formula | C11H25BN4O6S |
| Molecular Weight | 352.22 g/mol |
| Exact Mass | 352.16 |
| IUPAC Name | (3R,4R)-3-amino-1-(2-aminopropylsulfamoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid |
| SMILES | CC(N)CNS(=O)(=O)N1C[C@@H](CCCB(O)O)[C@](N)(C(=O)O)C1 |
| InChI | InChI=1S/C11H25BN4O6S/c1-8(13)5-15-23(21,22)16-6-9(3-2-4-12(19)20)11(14,7-16)10(17)18/h8-9,15,19-20H,2-7,13-14H2,1H3,(H,17,18)/t8?,9-,11+/m1/s1 |
| InChIKey | IMHNYELMMKUJKO-SNZBGZMYSA-N |
| XLogP | -2.87 |
| TPSA | 179.21 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 352.22 |
| LogP ≤ 5 | -2.87 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155627365 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.